Safety of Vitamin D Supplementation in Older Persons
Completed · Phase 3
Conditions studied: Vitamin D Deficiency
In brief
This study will evaluate the safety over 6 months of two different doses of vitamin D (cholecalciferol) in men and women age 65 and older. It will also evaluate if supplementation with vitamin D improves physical performance.
Key facts
- Study ID
- NCT00681590
- Run by
- University of Miami
- People needed
- 105
- Starts
- 2008-04-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2017-01-26
Who can join
Age: 65 and older, up to 95. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- ambulatory
You may not qualify if…
- hypercalcemia
- hypercalciuria > 4 mg/kg body weight/day
- primary, secondary, or tertiary hyperparathyroidism
- renal insufficiency (serum creatinine > 2 mg/dL )
- history of nephrolithiasis
- treatment with vitamin D (ergocalciferol, cholecalciferol, calcitriol)
- treatment with anticonvulsants
- Paget's disease
- severe cardiac, pulmonary, hepatic, renal, or neurological disease
- life expectancy < 1 year
- participation in another trial
Where it is running
- University of Miami — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.